Skip to content

Evaluation of the project "Digital networking in conservative ophthalmology" (DIVA)

Evaluation of the project "Digital networking in conservative ophthalmology" (DIVA) - DIVA

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00040293
Enrollment
250000
Registered
2026-05-21
Start date
2027-06-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E10 E11 H36.0

Interventions

Group 1: In the intervention group, consisting of five districts in Thuringia, eight telemedicine screening units (TSUs) were established. Since April 1, 2026, telemedicine screenings for diabetic ret

Sponsors

Institut für Allgemeinmedizin, Universitätsklinikum Jena
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Diabetes Mellitus (Type 1 or 2)

Exclusion criteria

Exclusion criteria: No exclusion criteria for the retrospective analysis of billing data from the Thuringia Association of Statutory Health Insurance Physicians

Design outcomes

Primary

MeasureTime frame
The primary endpoint is the rate of diabetic retinopathy screenings performed among all eligible patients with diabetes mellitus in Thuringia. The rate is calculated on a quarterly basis. This primary endpoint is determined retrospectively based on billing data from the Thuringia Association of Statutory Health Insurance Physicians.

Secondary

MeasureTime frame
Secondary endpoints include health economic endpoints (e.g., the incremental cost-effectiveness ratio) and process evaluation endpoints (e.g., changes in care capacity, impact on travel distances).

Countries

Germany

Contacts

Public ContactVerena Vogt

Institut für Allgemeinmedizin, Universitätsklinikum Jena

verena.vogt@med.uni-jena.de+49 (0) 3641/9-395801

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026